ODINK DEBRA 4
4 · Anthera Pharmaceuticals Inc · Filed Apr 3, 2012
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Award
Stock Option (right to buy)
2012-03-30+160,000→ 160,000 totalExercise: $2.21Exp: 2022-03-30→ Common Stock (160,000 underlying)
Holdings
- 26,659
Common Stock
- 95,928(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Stock Option vests and becomes exercisable pro-rata monthly beginning January 3, 2012 (the "Vesting Start Date"). This Stock Option is completely vested on the fourth anniversary of the Vesting Start Date.